Towards safer risperidone prescribing in Alzheimer's disease.
CONCLUSIONS: Our findings argue for age- and MMSE-related dose adjustments and suggest that a single measure of the concentration-to-dose ratio could be used to identify those with slower drug clearance.
PMID: 33176899 [PubMed - as supplied by publisher]
Source: The British Journal of Psychiatry for Mental Science - Category: Psychiatry Tags: Br J Psychiatry Source Type: research
More News: Alzheimer's | Men | Psychiatry | Risperdal Consta | Science | Statistics | Study | UK Health